JoVE Journal
Cancer Research
Cancer Research
Un abonnement à JoVE est nécessaire pour afficher ce contenu.
Chapitres
résumé
The genetically tractable nematode Caenorhabditis elegans can be used as a simple and inexpensive model for drug discovery. Described here is a protocol to identify anticancer therapeutics that inhibit the downstream signaling of RAS and EGFR proteins.